SELLAS Life Sciences
SLS
#8000
Rank
NZ$0.49 B
Marketcap
NZ$3.37
Share price
3.16%
Change (1 day)
88.21%
Change (1 year)

Revenue for SELLAS Life Sciences (SLS)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SELLAS Life Sciences from 2007 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 NZ$1.57 M-85.84%
2021 NZ$11.12 M322.55%
2020 NZ$2.63 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A-100%
2014 NZ$9.82 M224.68%
2013 NZ$3.02 M
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2007 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA